Literature DB >> 66909

Antiviral activities of acyl derivatives of 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosylcytosine in cell culture.

K Sato, A Nomura, J G Moffatt.   

Abstract

Antiviral activities of acyl derivatives (3'-O-octanoyl and 3'-O-decanoyl) of 2,2'-anhydro-1-beta-d-arabinofuranosylcytosine (cyclo-C) and 1-beta-d-arabinofuranosylcytosine (Ara-C) were compared with other antiviral nucleosides, and some biological characteristics of the antiviral activity were investigated. Among those synthesized acyl derivatives, 3'-O-decanoyl ara-C was the most active against deoxyribonucleic acid viruses, with an activity comparable to that of Ara-C. Acyl derivatives of cyclo-C were somewhat less active than their Ara-C counterparts. In the value of therapeutic index, 1-beta-d-arabinofuranosyladenine was superior to the others, followed by 5-iodo-2'-deoxyuridine. In comparing the sensitivity of two serotypes of herpes simplex virus it was found that Ara-C and its ester, as well as its cyclo-C counterpart, were more active against the type 2 than the type 1 strain. The activity of 3'-O-decanoyl Ara-C, like that of its parent, was diminished by treatment with cytidine deaminase from mouse kidney, but 3'-O-decanoyl cyclo-C was resistant to this treatment. In comparative studies of 3'- and 5'-O-acyl Ara-C's, antivaccinia virus activity of 3'-O-palmitoyl Ara-C was significantly superior to its 5'-counterpart. The inhibitory activity of 5'-O-decanoyl Ara-C was markedly reduced by the presence of a threefold molar excess of eserine sulfate, a choline esterase inhibitor, whereas the 3'-acyl Ara-C was not affected by the inhibitor in any combination. This result indicates that enzymatic hydrolysis of the 3'-ester to Ara-C, which is inhibited by eserine sulfate, did not occur in this cell culture.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66909      PMCID: PMC351951          DOI: 10.1128/AAC.11.2.191

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Reactions of 2-acyloxyisobutyryl halides with nucleosides. Synthesis and biological evaluation of some 3"-acyl and 3',5'-diacyl derivatives of 1-beta-D-arabinofuranosylcytosine.

Authors:  E K Hamamura; M Prystasz; J P Verheyden; J G Moffatt
Journal:  J Med Chem       Date:  1976-05       Impact factor: 7.446

2.  Reactions of 2-acyloxyisobutyryl halides with nucleosides. 7. Synthesis and biological evaluation of some 2,2'-anhydro-1(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine hydrochlorides.

Authors:  E K Hamamura; M Prystasz; J P Verheyden; J G Moffatt
Journal:  J Med Chem       Date:  1976-05       Impact factor: 7.446

3.  Reactions of 2-acyloxyisobutyryl halides with nucleosides. 6. Synthesis and biological evaluation of some 3'-acyl derivatives of 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride.

Authors:  E K Hamamura; M Prystasz; J P Verheyden; J G Moffatt
Journal:  J Med Chem       Date:  1976-05       Impact factor: 7.446

4.  Studies on the mode of action of 2,2'-anhydro-1- -D-arabinofuranosylcytosine.

Authors:  M C Wang; R A Sharma; A Bloch
Journal:  Cancer Res       Date:  1973-06       Impact factor: 12.701

5.  The effect of cytosine arabinoside on virus production in various cells infected with herpes simplex virus types 1 and 2.

Authors:  R L Nutter; F Rapp
Journal:  Cancer Res       Date:  1973-01       Impact factor: 12.701

6.  Pyrimidine nucleosides. 6. Syntheses and anticancer activities of N4-substituted 2,2'-anhydronucleosides.

Authors:  T Kanai; M Ichino
Journal:  J Med Chem       Date:  1974-10       Impact factor: 7.446

7.  Combination chemotherapy with cytosine arabinoside and rubidomycin in 30 cases of acute granulocytic leukemia.

Authors:  E Gluckman; A Basch; B Varet; B Dreyfus
Journal:  Cancer       Date:  1973-03       Impact factor: 6.860

8.  Oral and parenteral activity of 2,2'-anhydro-1- -D-arabinofuranosyl-5-fluorocytosine against both intraperitoneally and intracerebrally inoculated mouse leukemia.

Authors:  J J Fox; E A Falco; I Wempen; D Pomeroy; M D Dowling; J H Burchenal
Journal:  Cancer Res       Date:  1972-10       Impact factor: 12.701

9.  ara-Cytidine acylates. Use of drug design predictors in structure-activity relationship correlation.

Authors:  W J Wechter; M A Johnson; C M Hall; D T Warner; A E Berger; A H Wenzel; D T Gish; G L Neil
Journal:  J Med Chem       Date:  1975-04       Impact factor: 7.446

10.  Susceptibility of herpesviruses to cytosine arabinoside: standardization of susceptibility test procedure and relative resistance of herpes simplex type 2 strains.

Authors:  M Fiala; A Chow; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

View more
  1 in total

1.  Comparative study of the antiviral activity of acyl derivatives of 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine and other nucleosides against encephalitis in mice.

Authors:  S Nishiyama; K Sato; T Yamanaka; J G Moffatt
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.